SEC Form 4 · accession 0001209191-18-051580
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brady Johnson
Officer — Dir. of Finance & Controller
Period of report
Sep 14, 2018
Accepted (ET)
Sep 18, 2018 · 7:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.25 | Sep 14, 2018 | A | 4,000 | A | — | Sep 13, 2028 | Common Stock | 4,000 | 4,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest monthly over 36 months beginning on the one-month anniversary of September 14, 2018 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the three year anniversary of the Vesting Commencement Date.